PDX Trial Center for Breast Cancer Therapy
PDX Trial Center for Breast Cancer Therapy
批准号:
10200511
负责人:
Michael T. Lewis
金额:
$12.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-25 至 2022-08-31
关键词:
AnimalsAreaBioinformaticsBiometryBreastBreast Cancer PatientBreast Cancer therapyCancer BiologyCancer EtiologyCarboplatinCause of DeathCellsCellular biologyCessation of lifeClinicalClinical TrialsClinical Trials NetworkCollaborationsCollectionCommunicationComprehensive Cancer CenterDataDevelopmentDiagnosisDiseaseDrug CombinationsDrug TargetingElementsEnvironmentFDA approvedFosteringFundingFutureGenerationsGenomicsGoalsGrantHumanInstitutesInstitutionInvestigational DrugsInvestigational TherapiesLaboratoriesMalignant NeoplasmsMammary NeoplasmsMedical OncologyMedicineMetastatic breast cancerModelingMolecularMolecular GeneticsMusNational Cancer InstituteOncologyOrganoidsPathologyPatient-derived xenograft models of breast cancerPatientsPharmaceutical PreparationsPharmacotherapyPilot ProjectsPopulationPreclinical Drug EvaluationRecommendationRecurrenceReproducibilityResearchResearch PersonnelResearch Project GrantsResourcesSiteSourceStructureSystemTechnologyTestingTherapeuticTranslational ResearchWomanWorkXenograft ModelXenograft procedureanticancer researchbaseclinical investigationcohortcollegedrug testingexperiencein vivoindustry partnerinnovationmalignant breast neoplasmmembermultidisciplinarynew technologynovelnovel drug combinationnovel strategiesnovel therapeutic interventionparent projectpre-clinicalprecision medicinepreclinical trialprogramsresponsestandard of caretherapeutic evaluationtreatment strategytumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Active pilot project programs are an invaluable source of new ideas, and can serve to bring novel models and
technologies to a Center. Similarly, interactions and activities between other Centers in the PDXNet will also
enrich each Center by leveraging expertise and capabilities at other institutions. The goals of the Pilot Projects
and Trans-Network Activities Core are:
1. To fund innovative pilot projects within the PDTC to develop new technologies or explore innovative new
approaches related to the parent projects.
2. To fund trans-PDXNet collaborative projects to enhance the impact of each Center and of the network.
3. To fund collaborative projects between the PDTC and non-PDXNet investigators in a novel area related
to the advancement of the Center’s goals.
We have developed an approach to solicit Intra-PDTC and non-PDXNet pilot project applications on an annual
basis and review applications using a thoughtfully structured committee comprising key expertise in the Center
and utilizing the PDTC Advisory Boards. Major criteria for review of applications will include innovation,
significance, conceptual and scientific rigor, the potential to further the goals of the PDTC, and the potential for
future external funding. We will also fund Cross-PDXNet collaborative projects based on recommendations from
the PDXNet Steering Committee.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core-001
-
批准号:10710331
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2022
-
负责人:Michael T. Lewis
-
依托单位:
Core-001
-
批准号:10710333
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2022
-
负责人:Michael T. Lewis
-
依托单位:
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER
-
批准号:10688170
-
项目类别:
-
资助金额:$62.02万
-
财政年份:2019
-
负责人:Michael T. Lewis
-
依托单位:
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER
-
批准号:10241425
-
项目类别:
-
资助金额:$63.29万
-
财政年份:2019
-
负责人:Michael T. Lewis
-
依托单位:
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER
-
批准号:10020941
-
项目类别:
-
资助金额:$63.29万
-
财政年份:2019
-
负责人:Michael T. Lewis
-
依托单位:
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER
-
批准号:10478972
-
项目类别:
-
资助金额:$62.02万
-
财政年份:2019
-
负责人:Michael T. Lewis
-
依托单位:
Multi-omic, Exposure-informed, Genealogical Approach (mErGE)
-
批准号:10370622
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
PDX Trial Center for Breast Cancer Therapy
-
批准号:9446429
-
项目类别:
-
资助金额:$248.22万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance
-
批准号:10681678
-
项目类别:
-
资助金额:$22.4万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
Targeting mitochondrial dependencies in chemo resistant triple negative breast cancer
-
批准号:10581266
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
PDX Trial Center for Breast Cancer Therapy
-
批准号:10732947
-
项目类别:
-
资助金额:$118.71万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
PDX Core
-
批准号:10732949
-
项目类别:
-
资助金额:$19.79万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance
-
批准号:9446435
-
项目类别:
-
资助金额:$95.03万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
PDX Trial Center for Breast Cancer Therapy
-
批准号:9985272
-
项目类别:
-
资助金额:$124.07万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
PDX Trial Center for Breast Cancer Therapy
-
批准号:10223224
-
项目类别:
-
资助金额:$124.06万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
Tolinapant efficacy in a subset of triple negative breast cancers
-
批准号:10581272
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
PDX Trial Center for Breast Cancer Therapy
-
批准号:10005183
-
项目类别:
-
资助金额:$124.07万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
Research Project 1: Enhancing neoadjuvant therapy to prevent breast cancer recurrence
-
批准号:10732951
-
项目类别:
-
资助金额:$19.79万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
PDX Trial Center for Breast Cancer Therapy
-
批准号:10200553
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance
-
批准号:10223230
-
项目类别:
-
资助金额:$46.71万
-
财政年份:2017
-
负责人:Michael T. Lewis
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: